Molecular diagnosis of cystic fibrosis: Comparison of four analytical procedures

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 1, 2003, Pages 26-32

  Tomaiuolo, Rossella ^a   Spina, Mariacristina ^b   Castaldo, Giuseppe ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

Author keywords

Allele specific oligonucleotide dot blot (ASO dot blot); Amplification refractory mutation system (ARMS); Cystic fibrosis; Molecular diagnosis; Oligonucleotide ligation assay (OLA); Reverse dot blot

Indexed keywords

DNA;

ANALYTIC METHOD; ARTICLE; AUTOMATION; CAPILLARY ELECTROPHORESIS; COHORT ANALYSIS; CONTROLLED STUDY; CYSTIC FIBROSIS; DENATURING GRADIENT GEL ELECTROPHORESIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DOT HYBRIDIZATION; ETHNIC GROUP; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTERMETHOD COMPARISON; ISOTOPE LABELING; OBSERVER VARIATION; PRIORITY JOURNAL; REPRODUCIBILITY; SCREENING TEST;

COST-BENEFIT ANALYSIS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA MUTATIONAL ANALYSIS; EXONS; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMANS; ITALY; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 0037214955     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.006     Document Type: Article

References (23)

1. Shoshani T, Augarten A, Gazit E, Bashan N, Yahav Y, Rivlin Y, et al. Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease. Am J Hum Genet 1992; 50:222-8.
2. Dork T, Kalin N, Stuhrmann M, Schmidtke J, Tummler B. A termination mutation (2143delT) in the CFTR gene of German cystic fibrosis patients. Hum Genet 1992; 90:279.
3. Chevalier-Porst F, Chomel JC, Hillaire D, Kitzis A, Kaplan JC, Goutaland R, et al. A nonsense mutation in exon 4 over the cystic fibrosis gene frequent among the population of the Reunion Island. Hum Mol Genet 1992; 1:647.
4. Rendine S, Calafell F, Cappello N, Gagliardini R, Caramia G, Rigillo N, et al. Genetic history of cystic fibrosis mutations in Italy. I. Regional distribution. Ann Hum Genet 1997; 61:411-24.
5. Castaldo G, Fuccio A, Cazeneuve C, Picci L, Salvatore D, Raia V, et al. Detection of five rare cystic fibrosis mutations peculiar to southern Italy: implications in screening for the disease and phenotype characterization for patients with homozygote mutations. Clin Chem 1999; 45:957-62.
6. Grody WW, Desnick RJ, Carpenter NJ, Noll WW. Diversity of cystic fibrosis mutation-screening practices. Am J Hum Genet 1998; 62:1252-4.
7. Schwarz MJ. DNA diagnosis of cystic fibrosis. Ann Clin Biochem 1998; 35:584-610.
8. Girodon-Boulandet E, Cazeneuve C, Goossens M. Screening pratices for mutations in the CFTR gene ABCC7. Hum Mut 2000; 15:135-49.
9. Schwartz MK. Genetic testing and the clinical laboratory improvement amendments of 1988: present and future. Clin Chem 1999; 45:739-45.
10. Prence EM. A practical guide for the validation of genetic tests. Genet Test 1999; 3:201-5.
11. Dequeker E, Cuppens H, Dodge J, Estivill X, Goossens M, Pignatti PF, et al. Recommendations in a nutshell. Eur J Hum Genet 2000; 8:S1-S24
12. Dequeker E, Cassiman JJ. Genetic testing and quality control in diagnostic laboratories. Nature Genetics 2000; 25:259-60.
13. Castaldo G, Rippa E, Sebastio G, Raia V, Ercolini P, De Ritis G, et al. Molecular epidemiology of cystic fibrosis mutations and haplotype in southern Italy evaluated with an improved semiautomated robotic procedure. J Med Genet 1996; 34:475-9.
14. Fanen P, Ghanem N, Vidand M, Besmond C, Martin J, Costes B, et al. Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions. Genomics 1992; 13:770-6.
15. Costes B, Fanen P, Goossens M, Ghanem N. A rapid, efficient, and sensitive assay for simultaneous detection of multiple cystic fibrosis mutations. Hum Mutat 1993; 2:185-91.
16. Dequeker E, Cassiman JJ. Evaluation of CFTR gene mutation testing methods in 136 diagnostic laboratories: report of a large European external quality assessment. Eur J Hum Genet 1998; 6:165-75.
17. Dequeker E, Cuppens H, Dodge J, Estivill X, Goossens M, Pignatti PF, et al. Recommendations for quality improvement in genetic testing for cystic fibrosis European Concerted Action on Cystic Fibrosis. Eur J Hum Genet 2000; 8:S2-24.
18. Houdayer C, Cazeneuve C, Cougoureux E, Magnier C, Tredano M, Aymard P, et al. Clinical evaluation of the CF(12)m cystic fibrosis DNA diagnostic kit. Clin Chem 1998; 44:1346-8.
19. Friedman KJ, Heim RA, Knowles MR, Silverman LM. Rapid characterization of the variable length polythymidine tract in the cystic fibrosis (CFTR) gene: association of the 5T allele with selected CFTR mutations and its incidence in atypical sinopulmonary disease. Hum Mutat 1997; 10:108-15.
20. Castaldo G, Martinelli P, Massa C, Fuccio A, Grosso M, Rippa E, et al. Prenatal diagnosis of cystic fibrosis: a case of twin pregnancy diagnosis and review of 5 years experience. Clin Chim Acta 2000; 298:121-33.
21. Cheadle JP, Goodchild MC, Meredith AL. Direct sequencing of the complete CFTR gene: the molecular characterisation of 99.5% of CF chromosomes in Wales. Hum Molec Genet 1993; 2:1551-6.
22. Bonizzato A, Bisceglia L, Marigo C, Nicolis E, Bombieri C, Castellani C, et al. Analysis of the complete coding region of the CFTR gene in a cohort of CF patients from north-eastern Italy: identification of 90% of the mutations. Hum Gen 1995; 95:397-402.
23. Estivill X, Baucells C, Ramos C, and the Biomed CF Mutation Analysis Consortium. Geographic distribution and regional origin of 272 cystic fibrosis mutation in european populations. Hum Mutat 1997; 10:135-54.